Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126863211 | 12686321 | 1 | I | 20160412 | 20160825 | 20160825 | EXP | US-JAZZ-2016-US-006946 | JAZZ | 0.00 | F | Y | 0.00000 | 20160825 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126863211 | 12686321 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 126863211 | 12686321 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
| 126863211 | 12686321 | 3 | SS | FLONASE | FLUTICASONE PROPIONATE | 1 | UNKNOWN DOSE | U | 0 | ||||||||||
| 126863211 | 12686321 | 4 | C | Alyacen | 2 | U | 0 | ||||||||||||
| 126863211 | 12686321 | 5 | C | FORADIL | FORMOTEROL FUMARATE | 1 | U | 0 | |||||||||||
| 126863211 | 12686321 | 6 | C | Multivitamin | VITAMINS | 1 | U | 0 | |||||||||||
| 126863211 | 12686321 | 7 | C | QVAR | BECLOMETHASONE DIPROPIONATE | 1 | U | 0 | |||||||||||
| 126863211 | 12686321 | 8 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | U | 0 | |||||||||||
| 126863211 | 12686321 | 9 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
| 126863211 | 12686321 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 126863211 | 12686321 | 11 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126863211 | 12686321 | 12 | C | SUDAFED | PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126863211 | 12686321 | 13 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126863211 | 12686321 | 1 | Narcolepsy |
| 126863211 | 12686321 | 3 | Hypersensitivity |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126863211 | 12686321 | Epistaxis | |
| 126863211 | 12686321 | Hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126863211 | 12686321 | 1 | 201507 | 201508 | 0 | |
| 126863211 | 12686321 | 2 | 201508 | 0 |